Table 1.
Participants demographic and baseline characteristics by treatment groups. PS50, PhytoSERM 50gm/day; PS100, PhytoSERM 100mg/day.
| Placebo (n=16) |
PS50 (n=18) |
PS100 (n=12) |
p value | |
|---|---|---|---|---|
| Age, yrs, mean (SD) | 53.9 (3.14) | 53.8 (3.78) | 55.3 (2.83) | 0.43 |
| Education, yrs, mean (SD) | 18.2 (2.59) | 16.6 (2.79) | 17.0 (4.29) | 0.25 |
| Hispanic or Latino, n (%) | 2 (12.5%) | 4 (22.2%) | 3 (25.0%) | 0.67 |
| Race | 0.34 | |||
| Asian | 0 | 2 (11.1%) | 2 (16.67%) | |
| African-American | 1 (6.25%) | 1 (5.56%) | 0 | |
| White | 15 (93.75%) | 12 (66.67%) | 8 (66.67%) | |
| unknown | 0 | 3 (16.67%) | 2 (16.67%) | |
| Baseline Daily Hot Flash Frequency, mean (SD) | 2.4 (2.2) | 3.2 (2.5) | 4.4 (3.6) | 0.23 |
| Baseline RAVLT LOT, mean (SD) | 15.3 (5.4) | 12.5 (6.4) | 17.5 (2.8) | 0.09 |
| Baseline Trail B Time,s, mean (SD) | 50.3 (15.3) | 55.9 (15.7) | 52.5 (12.9) | 0.35 |